Ayman Semaan is Market Access and Pricing Lead at Biologix, where he has led access and pricing strategy across the Gulf, Levant and North Africa since 2015. His portfolio spans rare diseases, haemato-oncology, neurology, immunology and cardio-metabolic therapies. He has twenty years of experience in the pharmaceutical industry and began his career in sales and marketing at Algorithm Pharmaceutical Manufacturers, latterly as Marketing Manager for cardio-metabolic products across the Middle East and North Africa. He served as Director of Communications for the Lebanese chapter of ISPOR from 2023 to 2025 and is a member of HTAi.
